Tapinarof Under FDA Review for Treating Atopic Dermatitis :

Approved in 2022 for psoriasis, the manufacturer has submitted an application for approval of tapinarof cream for treating atopic dermatitis in adults and children 2 years of age and older.

Related Keywords

, Drug Administration , Dermavant Sciences , New Drug Application , Validated Investigator Global Assessment , Atopic Dermatitis , Dermatitis , Atopic Eczema , Children , Child , Childhood , Ediatrics , Kids , Psoriasis , Otolaryngology , Nt Specialty , Ead And Neck Surgery Ent Speciality , Contact Dermatitis , Folliculitis , Common Cold , Cute Nasopharyngitis , Plaque Psoriasis , Pruritus , Pruritis , Pitch , Receptors , Headache , Skin And Soft Tissue Infection ,